Soligenix (NASDAQ: $SNGX) Unveils Two-Pronged Approach To Tackle Rare Diseases \u0026 Unmet Medical Needs

(2:22)

Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

(6:31)

Soligenix Investor Overview

(1:37)

Soligenix, Inc - Superlative Performance in Rare Diseases

(34:41)

\

(8:55)

Soligenix Investor Overview

(2:8)

Soligenix, Inc.'s interview with Dr. Christopher J. Schaber, Chairman, President, and CEO

(8:55)

Soligenix: Rising to the Challenges of Rare Disease Treatment

(3:16)

Soligenix; Importance of the Proposed Reverse Stock Split

(5:34)

Soligenix's Mission in Biotech: An Interview with CEO Dr. Chris Schaber

(8:25)

Soligenix: Developing \u0026 Commercializing Treatments for Rare Diseases with Unmet Needs

(2:6)

Investor Watch: Soligenix, Inc Stock Analysis \u0026 Price Predictions for Thursday

(11:11)

This Week on RedChip TV: KnightScope, Soligenix Inc. \u0026 Genetic Technologies

(27:2)

Soligenix's (NASDAQ:SNGX) Breakthrough Therapies for Rare Diseases – Corporate Update

(7:55)

Soligenix; Announcing New FDA Drug Application Submission for Cutaneous T-cell Lymphoma

(5:37)

Soligenix, Inc. and SGX942, Taking On Oral Mucositis (NasdaqCM: SNGX)

(2:58)

Working at Amgen

(2:22)

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

(7:)

GSK – Our story

(3:57)

Soligenix, Inc. (NASDAQ: SNGX)

(32:45)

Soligenix; An Introduction to Chief Scientific Officer Dr. Oreola Donini

(6:22)

Inside Soligenix: Innovations in Rare Disease Therapies

(2:11)